{
  "nctId": "NCT05283148",
  "briefTitle": "Sickle Cell Disease (SCD) Bone Pain Study",
  "officialTitle": "Association Between Low Bone Density, Vertebral Fractures, and Pain in Sickle Cell Disease",
  "protocolDocument": {
    "nctId": "NCT05283148",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2023-05-19",
    "uploadDate": "2025-04-01T01:17",
    "size": 536770,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05283148/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 53,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2022-11-03",
    "completionDate": "2026-07-31",
    "primaryCompletionDate": "2024-04-30",
    "firstSubmitDate": "2022-03-07",
    "firstPostDate": "2022-03-16"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Age 18-80 years with SCD (any genotype, confirmed by hemoglobin electrophoresis or high performance liquid chromatography)\n* Ability to provide written informed consent\n* Ability to lay on a DXA scanner\n* Negative urine pregnancy test for women of childbearing potential at study entry\n\nExclusion Criteria:\n\n* Pregnant women\n* Adults unable to consent\n* Individuals who are not yet adults (infants, children, teenagers)\n* Prisoners\n* Hospitalizations (any cause) within 2 weeks of study entry",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "80 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Lumbar Spine Bone Mineral Density",
        "description": "Areal bone mineral density of the lumbar spine measured by dual-energy X-ray absorptiometry (DXA) scan and reported in grams per square centimeter.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Lumbar Spine Bone Mineral Density-Z-scores",
        "description": "Number of standard deviations between measured lumbar spine bone mineral density (g/cm2) for each participant and mean lumbar spine bone mineral density (g/cm2) of the reference population. A Z-score of 0 represents the mean of the reference population. A negative Z-score means the measured bone mineral density values are lower (worse) the reference mean, while positive Z-scores mean they are above/higher. Bone mineral density Z-scores ≤ -2 indicates low bone density.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Total Hip Bone Mineral Density (BMD)",
        "description": "Areal bone mineral density of the total hip measured by dual-energy X-ray absorptiometry (DXA) scan and reported in grams per square centimeter.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Total Hip Bone Mineral Density-Z-scores",
        "description": "Number of standard deviations between measured total hip bone mineral density (g/cm2) for each participant and mean total hip bone mineral density (g/cm2) of the reference population. A Z-score of 0 represents the mean of the reference population. A negative Z-score means the measured bone mineral density values are lower (worse) the reference mean, while positive Z-scores mean they are above/higher. Bone mineral density Z-scores ≤ -2 indicates low bone density.",
        "timeFrame": "At enrollment"
      },
      {
        "measure": "Femoral Neck Bone Mineral Density (BMD)",
        "description": "Areal bone mineral density of the femoral neck measured by dual-energy X-ray absorptiometry (DXA) scan and reported in grams per square centimeter.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Femoral Neck Bone Mineral Density Z-scores",
        "description": "Number of standard deviations between measured lumbar spine bone mineral density (g/cm2) for each participant and mean lumbar spine bone mineral density (g/cm2) of the reference population. A Z-score of 0 represents the mean of the reference population. A negative Z-score means the measured bone mineral density values are lower (worse) the reference mean, while positive Z-scores mean they are above/higher. Bone mineral density Z-scores ≤ -2 indicates low bone density.",
        "timeFrame": "Baseline"
      },
      {
        "measure": "Adult Sickle Cell Quality of Life Measurement System (ASCQ-Me) Pain Impact T-scores",
        "description": "Patient-reported outcome measure of pain impact in the preceding 7 days before bone density measurements. The Adult Sickle Cell Quality of Life Measurement System (ASCQ-Me) pain impact T-scores range from about 30-100. The ASCQ-Me pain impact T-score has standardized mean T-score of 50 and standard deviation of 10, which were derived from a reference population of ambulatory adult with sickle cell disease across the United States. ASCQ-Me pain impact T-scores less than 50 are lower/worse than the reference mean (more severe pain impact), while pain impact T-scores greater than 50 are above/better than the reference mean (less severe pain impact)",
        "timeFrame": "Baseline"
      }
    ],
    "secondary": [
      {
        "measure": "Spinal Deformity Index",
        "description": "The spinal deformity index (SDI) is a semi-quantitative measure of number and severity of vertebral fractures observed on lateral spine X-rays of the thoracolumbar spine. To calculate the SDI, vertebrae are assigned a score as follows: 0 (no fracture), 1 (mild fracture), 2 (moderate fracture), and 3 (severe fracture). The total SDI is the summation of all T12-L4 vertebrae measured on the lateral spine X-rays. Minimum SDI =0 and Maximum SDI=15. Higher scores mean increased (worse) fracture burden, lower scores mean decreased (less) fracture burden.",
        "timeFrame": "Baseline"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 7,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 8
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 79,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:30:03.762Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}